150 related articles for article (PubMed ID: 15491048)
1. Influence of the size of micronized active pharmaceutical ingredient on the aerodynamic particle size and stability of a metered dose inhaler.
Berry J; Kline LC; Sherwood JK; Chaudhry S; Obenauer-Kutner L; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2004 Aug; 30(7):705-14. PubMed ID: 15491048
[TBL] [Abstract][Full Text] [Related]
2. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
[TBL] [Abstract][Full Text] [Related]
3. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler.
Berry J; Heimbecher S; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2003 Sep; 29(8):865-76. PubMed ID: 14570307
[TBL] [Abstract][Full Text] [Related]
4. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
Berry J; Kline LC; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
[TBL] [Abstract][Full Text] [Related]
5. Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
Pu Y; Kline LC; Khawaja N; Van Liew M; Berry J
Drug Dev Ind Pharm; 2015 May; 41(5):737-43. PubMed ID: 24641447
[TBL] [Abstract][Full Text] [Related]
6. Particle size coarsening induced by valve silicone in a metered dose inhaler.
Sherwood JK; Alex S; Salama G; Obenauer-Kutner L; Huyck S; Berry J; Sequeira J; Brouet G; Marie C
Drug Dev Ind Pharm; 2007 Feb; 33(2):155-62. PubMed ID: 17454047
[TBL] [Abstract][Full Text] [Related]
7. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
8. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
9. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
[TBL] [Abstract][Full Text] [Related]
10. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
11. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
12. Drug Delivery from an Innovative LAMA/LABA Co-suspension Delivery Technology Fixed-Dose Combination MDI: Evidence of Consistency, Robustness, and Reliability.
Doty A; Schroeder J; Vang K; Sommerville M; Taylor M; Flynn B; Lechuga-Ballesteros D; Mack P
AAPS PharmSciTech; 2018 Feb; 19(2):837-844. PubMed ID: 29019170
[TBL] [Abstract][Full Text] [Related]
13. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
14. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
Pu Y; Kline LC; Berry J
Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
[TBL] [Abstract][Full Text] [Related]
15. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic charge characteristics of aerosols produced from metered dose inhalers.
Kwok PC; Glover W; Chan HK
J Pharm Sci; 2005 Dec; 94(12):2789-99. PubMed ID: 16258995
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
AAPS PharmSciTech; 2015 Feb; 16(1):192-201. PubMed ID: 25273026
[TBL] [Abstract][Full Text] [Related]
18. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI).
Guo C; Ngo D; Ahadi S; Doub WH
AAPS PharmSciTech; 2013 Sep; 14(3):1004-11. PubMed ID: 23780781
[TBL] [Abstract][Full Text] [Related]
20. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
